Last updated : August 14, 2026 8:30 am
Beauty and wellness products are shifting from basic functions to concept-based, benefit-driven solutions, such as targeted anti-aging and sun protection
Galaxy Surfactants reported consolidated revenue of Rs. 5,270 crore in FY2025-26 with improving specialty performance and premium product contribution. Major factors that helped the company to navigate demand volatility and raw material fluctuations during the year?
If you look at FY26, it was clearly a year where external volatility tested the resilience of the business—be it demand softness, customer-led reformulations, or continued volatility in oleochemical and petrochemical inputs. What helped us navigate this environment was fundamentally the strength of our business model and our operating discipline.
On the demand side, India continued to demonstrate strong underlying resilience with healthy long-term growth potential across customer tiers. That said, during the year we did see an impact from customer-led reformulations, largely driven by the persistence of elevated oleochemical prices over the past five to six quarters. This did weigh on growth in FY26, particularly with Tier-1 customers, but we do not see this as a structural shift. Importantly, this volume impact was largely offset by robust growth from non-Tier 1 customers and the rapidly expanding D2C segment, which continues to be an emerging opportunity for us.
In the AMET region, demand softness was more pronounced, driven by a combination of high input costs and increasing local competition, which impacted offtake during the year. In the Rest of the World, we saw a mixed trend—while demand for specialty products in the US was impacted from Q2 onwards due to tariff-related disruptions, other regions such as LATAM and APAC remained relatively strong and continued to deliver stable growth.
Overall, what played out clearly during the year was the strength of our diversified operating model. Our balanced mix of performance surfactants and specialty ingredients, coupled with a geographically diversified customer base, allowed us to absorb and offset regional and segmental volatility. While the performance surfactants segment saw some pressure due to reformulations, our specialty portfolio—as well as growth from Tier 2/3 and D2C customers—provided resilience and stability to the overall business.
Secondly, over the years we have built a robust risk management and supply chain framework, which has been a key enabler in managing raw material volatility. Given the fluctuations in fatty alcohol prices and logistics costs, our approach of multi-sourcing, strong vendor relationships, and maintaining an optimal mix between contract and spot procurement provided us with flexibility. In addition, agility in pricing and proactive inventory management helped us mitigate disruptions and protect margins to a large extent. Overall, FY26 reinforced the importance of discipline, diversification and preparedness—principles that continue to define the way we manage the business through cycles.
Specialty Care Products continue to gain share in Galaxy’s portfolio. How important is the transition from commodity surfactants to high-value specialty ingredients in driving long-term margin expansion and global competitiveness?
This transition is key to our long-term strategy and value creation model. While Galaxy’s objective is to grow both legs of the business; value creation and global competitiveness today is a derivative of being present across the HPBC ingredients value chain. While performance surfactants segment provides scale, operating leverage and leadership positions, in markets like India and AMET; specialty aids margin expansion. With premiumization being the key driver in many regions, globally we are seeing a gradual but steady shift towards specialty care ingredients and high-value formulations.
Specialty ingredients offer structural advantages. They are innovation-led and less commoditized, which improves pricing power, and they are part of niche and premium formulations, enabling us to partner with customers in developing products across masstige and prestige segments, which are inherently of higher value. Additionally, a large portion of the specialty, within both risen off and leave on segments, is concentrated in developed markets such as the Americas and Europe, where the opportunity size is significant.
We have already built a strong foundation in these markets through TRI-K, our premium specialty platform, which has demonstrated strong performance and high value addition. We see a similar opportunity emerging in the broader specialty and masstige segments as well.
Our Strategy 2030 is therefore very clear—we are not moving away from surfactants, but rather layering specialty capabilities on top of a strong base, thereby steadily improving both the quality of growth and the overall profitability profile of the business.
Galaxy Surfactants has consistently emphasized innovation-led growth in personal care and home care ingredients. Which emerging consumer trends are currently shaping your R&D priorities globally?
Our R&D priorities today are very closely aligned with evolving global consumer trends. One of the most significant shifts we are seeing is from basic functionality to more concept-based and benefit-driven products, whether it is anti-aging, sun protection, many claim based solutions. This is driving innovation in areas such as modern sun care actives, bio-based ingredients, and specialty conditioning agents.
At the same time, there is a strong and irreversible move towards clean beauty and sustainability. Consumers are far more conscious about ingredient safety, toxicity, and environmental impact, which is sharpening our focus on green chemistry, non-toxic preservation systems, and bio-based surfactants. Finally, the rapid emergence of D2C brands and personalization trends is accelerating the need for faster innovation cycles and customized formulation solutions. This plays very well to our strength as a formulation-driven organization, where we work closely with customers to co-create solutions aligned with evolving consumer needs.
The company has strengthened its presence in global markets including North America, Europe, and Asia-Pacific. Which geographies are currently witnessing the strongest demand recovery, and where do you see the biggest growth opportunities over the next five years?
In terms of recovery, we are seeing improving momentum in the Rest of the World markets, particularly towards the latter part of the year, with North America stabilizing and specialty-led growth gaining traction. India continues to remain structurally strong. The medium-term fundamentals—premiumization, income growth, penetration remain intact, and this will continue to be our primary growth engine. AMET has gone through a more challenging phase, but we have stabilized volumes and expect gradual improvement as macros normalize.
Looking ahead, the biggest growth opportunities over the next five years are clearly in: India – driven by penetration and premiumization; Americas – through Masstige and Prestige expansion across categories; and Europe – through specialty ingredients and localization with our new subsidiary.
Galaxy has been expanding its specialty ingredients portfolio for skin care, hair care, sun care, and preservatives. Which product segments are expected to contribute most significantly to revenue and EBITDA growth going forward?
Going forward, growth will be driven by a combination of new specialty portfolio and emerging application areas. We see strong contribution from: Leave-on segments – skincare, sun care, and cosmetics; specialty actives – anti-aging, hair growth, and conditioning; and non-toxic preservatives, green, and biobased chemistry. These segments are not only higher growth but also yield higher margins driving EBITDA growth.
The company has highlighted increasing focus on biotechnology, green chemistry, and naturally derived ingredients. How is Galaxy positioning itself to meet the growing global demand for sustainable and clean-label personal care products?
Sustainability is not a parallel initiative for us; it is deeply embedded in our strategy. We are focusing on: green chemistry and bio-based inputs; reducing impurities and improving safety standards; and developing non-toxic and regulatory compliant formulations. We have already demonstrated our capability to stay ahead of regulations—for example, in meeting stricter impurity norms in developed markets. When it comes to product development; we have over the past 5 years at Incosmetics Europe only launched products which are in sync with the principles of green chemistry – completely green end to end as today both the product as well as process of manufacturing need to be sustainable, clean, and green!
Galaxy Surfactants recently commissioned capacity expansions and process enhancement projects. Could you elaborate on the Capex roadmap for FY2026-27 and expected returns from these investments?
Over the last 2–3 years, we have undertaken significant investments focused on building both capacities and capabilities, particularly in the specialty segment. Some projects have already been commissioned and few remaining projects are nearing completion and will start getting commissioned from the first half of FY27. Going forward, our capital expenditure will be more calibrated. We will continue with our regular growth and maintenance capex, which is in the range of about Rs. 150 crore annually, along with selective debottlenecking investments. However, we do not foresee any major greenfield or large brownfield capex in the near term.
Typically, investments in specialty capacities have a gestation period of around 5–6 years, post which operating leverage starts playing out and returns improve meaningfully. If you look at our past cycles, this model has consistently delivered recovery in ROCE after the investment phase, and we expect a similar trajectory going forward as these new capacities start contributing.
Galaxy has highlighted its ambition to become a leading global specialty ingredients company. What strategic priorities will define the next phase of growth? Is it acquisitions, new chemistries, global partnerships, or deeper penetration in existing markets?
The next phase of our growth will be driven by a well-defined in Strategy 2030 which is multi-pronged strategy. This includes continued expansion of our specialty portfolio, diversification into Beauty & Wellness, deeper penetration in global markets such as the Americas and Europe, and a calibrated approach towards strategic partnerships and inorganic opportunities. It is not about relying on a single lever, but about executing across these priorities in a structured manner to build a stronger, more resilient and globally competitive business over time.
The company has invested significantly in R&D infrastructure and innovation centers. Could you share how collaborative innovation with customers is accelerating new product development and commercialization?
Our innovation model today is increasingly collaborative and customer-centric across the globe. We work closely with customers right from the concept stage—whether it is a fast-growing D2C brand or a global MNC—partnering with them across the entire product development lifecycle. This includes co-developing formulations, providing testing and validation support, and enabling scale-up for commercialization. This approach significantly reduces time to market while also strengthening customer engagement and stickiness, as we become a solution partner rather than just a supplier.
Sustainability reporting and ESG compliance are becoming increasingly critical for global ingredient suppliers. What measurable progress has Galaxy made in reducing carbon emissions, improving water efficiency, and increasing renewable energy usage?
We continue to make steady progress across our key sustainability priorities, including reducing emissions through improved energy efficiency, optimizing water usage across operations, and increasing our reliance on sustainable and responsibly sourced raw materials. What is important to highlight is that for us, ESG is not just about compliance—it is increasingly becoming a source of competitive advantage, especially in global markets where customers are placing greater emphasis on sustainability, traceability, and responsible sourcing.
Galaxy has spoken about integrating digitalization and smart manufacturing into its operations. How are technologies such as AI, automation, and data analytics helping improve operational efficiency and product consistency?
Digitalization is increasingly becoming a critical enabler of efficiency and scalability for us, and we are progressing towards building a digital factory across all our plants. We are deploying advanced tools such as AI and data analytics for demand forecasting and quality control, alongside automation to enhance operational efficiency. In parallel, we are integrating systems end-to-end—not only across manufacturing but also including logistics and supply chain management—to improve visibility, planning, and responsiveness across the value chain. This integrated digital ecosystem is helping us optimize logistics flows, improve delivery reliability, and better manage inventory and freight costs. Overall, these initiatives are driving improved cost efficiency, higher product consistency, and faster, more informed decision-making, enabling us to operate with greater agility in an increasingly dynamic environment.
India is increasingly emerging as a global hub for specialty chemicals and personal care ingredients under the China+1 strategy. How well positioned is Galaxy to capitalize on this shift?
India is emerging as a very compelling alternative in the global supply chain realignment. At Galaxy, we believe we are well positioned to capitalize on this shift, given our strong foundations. We operate with global quality standards, have long-standing relationships with leading multinational customers, and possess an integrated manufacturing and supply chain footprint that ensures reliability and scalability. Importantly, we are already seeing a clear increase in engagement from global customers who are actively looking to diversify sourcing towards India. Given our track record, capabilities, and customer alignment, we see this as a meaningful structural opportunity for long-term growth.
Looking ahead to FY2026-27 and beyond, what are your expectations regarding revenue growth, specialty product contribution, export demand, and profitability trajectory?
The past year has been quite dynamic, with multiple external headwinds including US tariff impacts, customer-led reformulations, and more recently, geopolitical developments such as the West Asia conflict, all of which influenced demand and supply dynamics.
However, the situation is now beginning to stabilize. The reversal of US tariffs has been particularly positive, and we are already seeing improved traction in the Americas market. In the near term, we have good visibility on recovery, and we expect volume growth to be at the higher end of our guidance range of 6–8%, with EBITDA per MT also trending towards the upper end of the Rs. 19,000–21,000 range.
Looking ahead, we expect growth to be supported by gradual improvement in volumes across segments, increasing contribution from specialty products, and rising export share, particularly from the Americas and Europe. At the same time, margins are expected to improve with a better product mix and higher specialty share. Overall, we remain confident of delivering sustainable growth with improving quality of earnings, fully aligned with our Strategy 2030 trajectory.